Women with gestational diabetes should be targeted to reduce cardiovascular risk

BMJ 2002; 325 doi: 10.1136/bmj.325.7370.966 (Published 26 October 2002)
Cite this as: BMJ 2002;325:966

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. V Toescu, research associate. (v.toescu@bham.ac.uk),
  2. S L Nuttall, postdoctoral fellow.,
  3. M J Kendall, professor of clinical pharmacology.,
  4. U Martin, senior lecturer in pharmacology.,
  5. F Dunne, senior lecturer in medicine.
  1. Division of Medical Sciences, Queen Elizabeth Hospital, Birmingham B15 2TH

    EDITOR —Sattar and Greer discuss the probability that complications in pregnancy may predispose women to vascular and metabolic disease in later life.1 The link between pregnancy complications and coronary heart disease remains unexplained. We believe that during pregnancy the hormonal and other stresses provoke cardiovascular and metabolic abnormalities in susceptible individuals, which may recur and become permanent as the patient ages. Many of these are coronary risk factors; disturbances in glucose metabolism, which underlie the development of gestational diabetes, are a good example.

    Triglyceride concentrations and …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL